The UK has now secured early access to three different types of promising COVID-19 vaccine candidates

The drug significantly cut the risk of developing severe disease and patients were twice as likely to recover […]

GSK to make equity investment of £130m in CureVac as part of the deal

Interim six-month data of RPGR gene therapy shows significant vision improvement in patients with X-linked retinitis pigmentosa

Researchers have now demonstrated that behavior therapy that exposes people to memories of their trauma doesn’t cause relapses […]

Researchers have developed a new drug candidate that kills triple negative breast cancer cells. The discovery will help […]

Initial findings from a new study show that immunotherapy for cancer won’t worsen complications for patients with the […]

Pfizer, BioNTech ink U.K. supply pact for 30 million COVID-19 vaccine doses kblankenship Mon, 07/20/2020 – 09:26

Bayer plays the long game with plans to double workforce at Berkeley biologics site aliu Mon, 07/20/2020 – […]

Niche vaccine player Valneva, UK tie up in coronavirus R&D and manufacturing deal esagonowsky Mon, 07/20/2020 – 11:16